Ahren
Venture capitalCambridge
Fund manager profile
Ahren is a venture fund manager based in Cambridge. SEC filings show 1 venture fund on record, most recently Ahren II LP filed May 2024.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 2 of 2 portfolio companiesBiotech ×2Deep Tech ×2Healthtech ×1New Materials ×1
Investments · 2 tracked
founders shown can be your intro pathBy year:2024 · 12018 · 12 dated
The company develops a 6-base sequencing platform (duet evoC) that simultaneously profiles methylation (5mC, 5hmC), genetic variants, and fragmentomics from a single cfDNA sample.
BiotechDeep TechHealthtechCambridge
Jason Mellad(Executive Officer, Director)Martin Murphy(Director)Bobby Yerramilli-Rao(Director)Somasundaram Subramaniam(Director)Timothy Rink(Director)Thomas Hulme(Director)
Co-investorsThird Point VenturesAhren Innovation CapitalGV (Google Ventures)New Science VenturesSequoia Capital
Constructive Bio is a biotechnology company that rewrites the genetic code to give cells access to non-canonical amino acid building blocks, expanding the range of proteins that can be designed, engineered, and manufactured.
BiotechDeep TechNew Materials
Jason Chin(Professor)
Co-investors+ND CapitalAmadeus Capital PartnersFine Structures VenturesGENERAL INCEPTIONLongeVCOMX Ventures+2 more
Portfolio news
latest coverage across their companiesConstructive Bio · nature.com · Oct 20, 2025
Frequently asked questions
- Where is Ahren located?
- Ahren is headquartered in Cambridge.